The inaugural New Jersey Strategic Advisory Board Members include representatives from: Bristol- Myers Squibb, Novartis Pharmaceutical Corporation, Ørsted, Overdeck Family Foundation, PSEG Foundation, and Siemens.
“We’ve been working for several years now to develop an infrastructure to improve STEM outcomes in New Jersey and lessen random acts of STEM, beginning with the New Jersey STEM Pathways Network, our priority groups, and STEM Learning Ecosystems” said Kim Case, Executive Director of the Research & Development Council and manager of its NJSPN initiative. “Coordinating STEM investments with the larger conversation about how we are going to tackle important STEM education and workforce program and policy challenges seemed like a fundamental next step.”
The Board will soon announce a competitive innovation fund that will allow potential grantees to apply for funding for their STEM initiatives.
To access more business news, visit NJB News Now.